Are serum cholesterol levels associated with silent brain infarcts? The Seiryo Clinic Study

Atherosclerosis

Volumn 210, Issue 2, 2010, Pages 674-677

  Asumi, Mihoko ^a,b,c   Yamaguchi, Tatsuo ^a,d   Saito, Kazumi ^b   Kodama, Satoru ^b   Miyazawa, Hidemitsu ^a   Matsui, Hiroshige ^a   Suzuki, Emiko ^c   Fukuda, Hiroshi ^d   Sone, Hirohito ^b  

^a Diagnostic Imaging Center   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c OCHANOMIZU UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

Author keywords

Cerebral infarction; Cholesterol; Magnetic resonance imaging; Multivariate analysis

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTERIAL WALL THICKNESS; ARTICLE; BRAIN INFARCTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL STUDY; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; HYPERURICEMIA; ISCHEMIC HEART DISEASE; JAPANESE; MALE; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; STROKE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BRAIN INFARCTION; CHOLESTEROL; CROSS-SECTIONAL STUDIES; HUMANS; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK;

EID: 77953229965     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.01.008     Document Type: Article

References (14)

1. Vermeer S.E., Longstreth W.T., Koudstaal P.J. Silent brain infarcts: a systematic review. Lancet Neurol 2007, 6:611-619.
2. Amarenco P., Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol 2009, 8:453-463.
3. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
4. Hougaku H., Matsumoto M., Handa N., et al. Asymptomatic carotid lesions and silent cerebral infarction. Stroke 1994, 25:566-570.
5. Japanese Society for the Detection of Asymptomatic Brain Disease, [accessed December 25, 2009]. http://www.snh.or.jp/jsbd/pdf/guideline2003.pdf.
6. Sasaki M., Hirai T., Taoka T., et al. Discriminating between silent cerebral infarction and deep white matter hyperintensity using combinations of three types of magnetic resonance images: a multicenter observer performance study. Neuroradiology 2008, 50:753-758.
7. Oncel C., Demir S., Güler S., et al. Association between cholesterols, homocysteine and silent brain infarcts. Intern Med J 2009, 39:150-155.
8. Vermeer S.E., Den Heijer T., Koudstaal P.J., et al. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2003, 34:392-396.
9. Das R.R., Seshadri S., Beiser A.S., et al. Prevalence and correlates of silent cerebral infarcts in the Framingham Offspring Study. Stroke 2008, 39:2929-2935.
10. Lewington S., Whitlock G., Clarke R., et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007, 370:1829-1839. Prospective Studies Collaboration.
11. Uehara T., Tabuchi M., Mori E. Risk factors for silent cerebral infarcts in subcortical white matter and basal ganglia. Stroke 1999, 30:378-382.
12. Kato T., Inoue T., Yamagishi S., et al. Low-density lipoprotein subfractions and the prevalence of silent lacunar infarction in subjects with essential hypertension. Hypertens Res 2006, 29:303-307.
13. Pullicino P. Review: silent brain infarcts are common in the elderly general population. Evid Based Med 2008, 13:88.
14. Shintani S., Kikuchi S., Hamaguchi H., Shiigai T. High serum lipoprotein(a) levels are an independent risk factor for cerebral infarction. Stroke 1993, 24:965-969.